Allstate Corp Amicus Therapeutics, Inc. Transaction History

Allstate Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $236,747 - $374,474	-30,006 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$9.82 - $12.44 $7,021 - $8,894	-715 Reduced 2.33%	30,006 $347,000
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $107,458 - $145,572	12,295 Added 66.73%	30,721 $293,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $8,631 - $10,623	-991 Reduced 5.1%	18,426 $178,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $37,103 - $96,227	4,033 Added 26.22%	19,417 $192,000
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $207,222 - $382,907	15,384 New	15,384 $355,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.